Teladoc Health, Inc.
TDOC · Healthcare
$6.26
Loading chart…
News
Latest headlines for this stock
Here's Why Investors Should Stay Neutral on TDOC Stock for Now
Teladoc Health (TDOC) is positioned for growth through chronic care expansion, international presence, and its upcoming Teladoc One platform, with the stock trading at a valuation discount. However, the company faces headwinds from declining BetterHelp revenues, intense virtual care competition, and persistent unprofitability with a $16.5 billion accumulated deficit.
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Teladoc Health, Inc. - TDOC
Pomerantz LLP is investigating potential securities fraud claims against Teladoc Health following the company's significant revenue guidance downgrade on July 29, 2026. Teladoc reduced its full-year 2026 revenue guidance from $2.48-$2.58 billion to $2.36-$2.45 billion, citing uncertainties in cash pay and business model transition. The announcement triggered a 38.32% stock price decline, falling $2.60 per share to $6.58.
AI in Patient Engagement Market Size to Reach USD 45.90 Billion by 2035 as Healthcare Automation Accelerates – SNS Insider
The global AI in Patient Engagement Market is projected to grow from USD 7.85 billion in 2025 to USD 45.90 billion by 2035, expanding at a CAGR of 19.34%. Growth is driven by widespread adoption of conversational AI, virtual health assistants, predictive analytics, and remote patient monitoring. North America leads with 38.50% market share, while Asia-Pacific is the fastest-growing region at 23.80% CAGR. Natural Language Processing dominates technology segment with 39.80% share, and cloud deployment accounts for 64.20% of the market.